TI
MDGL icon

Tidal Investments’s Madrigal Pharmaceuticals MDGL Stock Holding History

Tidal Investments’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$876K Buy
1,631
+80
+5% +$41K ﹤0.01% 1820
2026
Q1 		$812K Buy
+1,551
New +$741K ﹤0.01% 1586
2025
Q4 		– Sell
-2,209
Closed -$1.01M – 2256
2025
Q3 		$1.01M Buy
+2,209
New +$824K ﹤0.01% 1214

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Tidal Investments's MDGL Position: Q2 2026 in Review

Tidal Investments increased its Madrigal Pharmaceuticals (MDGL) stake by 5.2% in Q2 2026, buying an estimated $41K and bringing the position to 1,631 shares worth $876K. The position accounts for ﹤0.01% of the portfolio, ranked #1820.

Tidal Investments first reported a position in MDGL in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.01M in Q3 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Tidal Investments held 1,631 shares of Madrigal Pharmaceuticals worth $876K as of Q2 2026.
  • Tidal Investments bought 80 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $41K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Tidal Investments's portfolio in Q2 2026, its #1820 holding.
  • Tidal Investments first reported a position in Madrigal Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Tidal Investments's Madrigal Pharmaceuticals position peaked at $1.01M in Q3 2025.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.